Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.65 and traded as low as $0.46. Northwest Biotherapeutics shares last traded at $0.47, with a volume of 1,867,962 shares changing hands.
Northwest Biotherapeutics Price Performance
The business has a fifty day simple moving average of $0.54 and a 200 day simple moving average of $0.65. The firm has a market cap of $565.87 million, a price-to-earnings ratio of -7.83 and a beta of -0.68.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last announced its earnings results on Tuesday, March 5th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.45 million during the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
Recommended Stories
- Five stocks we like better than Northwest Biotherapeutics
- Canada Bond Market Holiday: How to Invest and Trade
- Charles Schwab Fortifies its Uptrend on EPS Beat
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Investing in Commodities: What Are They? How to Invest in Them
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
